ACP released new clinical guidance on outpatient treatment of acute episodic migraine with combination therapy in patients ...

While chronic migraine has a physical neurologic root cause, adding talk therapy to a chronic migraine treatment plan has been shown to help some people manage the condition. Talk therapy ...

The American College of Physicians (ACP) has developed new recommendations for treatment of acute episodic migraines in nonpregnant adults in outpatient settings.

Medically reviewed by Nicholas R. Metrus, MD Botox (onabotulinumtoxinA) is a preventive therapy for adults with chronic ...

Migraine disrupts daily life with invisible neurological pain, causing physical, emotional, and cognitive struggles that go ...

Pfizer has a second FDA approval for a migraine therapy stemming from its $11.6 billion Biohaven takeover, getting the go-ahead for intranasal therapy Zavzpret to sit alongside its fast-growing ...

Migraine is a common neurological syndrome that affects approximately 10–20% of the population. The pathophysiology of migraine is unclear. 5-hydroxytriptamine is a key mediator in the ...

"For some of the reasons, like acute therapy, the U.S. Headache Consortium recommends migraine-specific agents initially, and the AAFP is not quite that strong," King said. Her preference is for ...

Infusion therapy can be an effective treatment for migraine, but there are possible side effects. Know what they may be and how you can manage them.

Lasmiditan is a promising treatment for menstrual migraine, offering sustained pain relief comparable to or exceeding that of triptans. However, further research is needed to fully assess its safety ...

Researchers evaluated the global rates of incidence, prevalence, and disability-adjusted life years of migraine from 1990 to 2021.